Last reviewed · How we verify

NCT05487677

Subscapularis Repair Augmentation for Total Shoulder Arthroplasty

Recruiting now NA Last updated 3 March 2026
What this trial tests

NA trial testing BioBrace Augmentation in Shoulder Injuries in 100 participants. Currently enrolling.

Timeline
1 December 2023
Primary endpoint
1 September 2026
1 December 2028

Quick facts

Lead sponsorStanford University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date1 December 2023
Primary completion1 September 2026
Estimated completion1 December 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Shoulder Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this research is to compare the images obtained by ultrasound between a standard repair of the subscapularis tissue and after repair with a Biobrace. The secondary purpose is to determine if there are any clinical differences.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Commercial Biomaterial-Based Products for Tendon Surgical Augmentation: A Scoping Review on Currently Available Medical Devices.
    Pluchino M, Vivarelli L, Giavaresi G, Dallari D, et al · · 2025 · cited 2× · PMID 40278238 · DOI 10.3390/jfb16040130

Verify or expand the search:

Other recruiting trials for Shoulder Injuries

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05487677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing